Skip to content

Influence of the concentration of local anesthetics ropivacaine in the quality of regional anesthesia for carotid surgery.

Influence of the concentration of the local anesthetic ropivacaine in the quality of a ultrasound guided block of the regio collis lateralis for carotid endarterectomy: a prospective, randomized and controlled trail

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-002769-37-AT
Enrollment
Unknown
Registered
2012-09-26
Start date
2012-10-23
Completion date
Unknown
Last updated
2015-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional anesthesia for carotid endarterectomy surgery.

Interventions

Trade Name: Naropin Product Name: Ropivacain (Naropin) Pharmaceutical Form: Injection INN or Proposed INN: Ropivaca 7.5 mg/ml:1 ml solution for injection contains ropivacaine hydrochloride monohydrate

Sponsors

UK für Anästhesiologie und allgemeine Intensivmedizin, LKH Salzburg
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with elective scheduled carotid endarterektomy surgery under regional anesthesia Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 16

Exclusion criteria

Exclusion criteria: refusal to participate in the trail age < 18a gestation/breastfeeding contraindication for regional anesthesia inclusion in other trails

Design outcomes

Primary

MeasureTime frame
Main Objective: In this study the Influence of the concentration of the local anesthetic ropivacaine on the quality of the cervical plexus block for carotid endarterectomy will be evaluated. For this purpose two different concentrations of Ropivacaine will be compared (3,75% vs 7,5%).;Secondary Objective: Not applicable;Primary end point(s): amount of additional needed local anesthetics by the surgeon ;Timepoint(s) of evaluation of this end point: during the whole surgical procedure

Secondary

MeasureTime frame
Secondary end point(s): incidence to change to general anesthesia incidence of side effects linked to the regional anesthesia additional need of analgesics/sedation plasma concentration of the used local anesthetics duration of the surgery clamping time of the carotid artery cerebral oxygenation incidence of temporary neurological side effects blood pressure heartbeat per minute spO2 incidence of carotid shunting incidence of cardiovascular events effect on the diaphragm function needed inspiratory oxygen fraction patient statisfaction ;Timepoint(s) of evaluation of this end point: continuously recorded during the whole surgical procedure, as well as until 10h after the procedure

Countries

Austria

Contacts

Public ContactDr. Andreas Koköfer

Uk für Anästhesiologie, LKH Salzburg, SALK

a.kokoefer@salk.at004366244822710

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026